GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Jyong Biotech Ltd
The value of Jyong Biotech, a Taiwanese biotech company, is determined by its success in developing drugs based on plant extracts. Its potential share price will depend on the results of clinical trials and its ability to commercialize its products globally.
Share prices of companies in the market segment - Pharma other
Jyong Biotech's value as a pharmaceutical company is determined by its R&D potential. Its potential share price will depend on successful clinical trials, partnerships, and the ability to commercialize its developments. We classify it in the Pharma Other sector.
Broad Market Index - GURU.Markets
Jyong Biotech is a Taiwanese biopharmaceutical company developing herbal medicines for various ailments. As part of the GURU.Markets index, it represents the alternative medicine sector. The chart below represents the entire market. See how this niche player compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
MENS - Daily change in the company's share price Jyong Biotech Ltd
The daily price change of Jyong Biotech, a stock operating in the phytopharmaceuticals sector, reflects the high volatility of the biotech sector. Change_co shows the market's reaction to news about clinical trials and regulatory decisions. This metric is important for risk analysis in niche pharmaceutical companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma other
The biotech sector in which Jyong Biotech Ltd operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive Jyong's drug development business is to general trends and clinical trial news.
Daily change in the price of a broad market stock, index - GURU.Markets
Jyong Biotech is a biopharmaceutical company developing drugs for the treatment of various diseases. The biotech sector is known for its high volatility. The chart below shows average daily fluctuations in this industry, allowing one to assess how Jyong Biotech's performance aligns with overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Jyong Biotech Ltd
Jyong Biotech is a pharmaceutical company developing new drugs. Its shares, like many in the sector, are volatile and react to news about clinical trials. These scientifically driven movements are part of the overall stock market landscape.
Annual dynamics of market capitalization of the market segment - Pharma other
Jyong Biotech, as a niche pharmaceutical company, focuses on developing specific drugs. The success of such companies is not dependent on general market trends, but rather on clinical trial results. Its performance, compared to the sector, will reflect the unique, high-risk profile typical of biotech innovators.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Jyong Biotech, a publicly traded company with the ticker symbol MENS, could not be identified on US exchanges. It is likely a privately held or foreign company not represented on the US market. Without publicly available stock price data, analyzing its market performance in the context of global economic cycles is impossible.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Jyong Biotech Ltd
Jyong Biotech's value as a biopharmaceutical company will depend on its R&D cycle. Monthly fluctuations on the chart will reflect not revenue, but news about the progress of its drug clinical trials, the success of which will determine the company's entire future valuation.
Monthly dynamics of market capitalization of the market segment - Pharma other
Jyong Biotech is a pharmaceutical company focused on developing plant-based medicines for specific diseases. They operate in a niche area of modern medicine. The chart below shows the overall dynamics in the biotech sector, where investors are evaluating the potential of unconventional treatment approaches.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of small biotech companies thrive on news about their clinical trials. The chart below shows the overall market sentiment. Is Jyong Biotech navigating its own world, where one successful trial result can outweigh any market storm?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Jyong Biotech Ltd
Shares of Jyong Biotech, a biotech company developing drugs based on plant extracts, are extremely volatile. Their weekly performance depends almost entirely on news about clinical trials, regulatory decisions, and scientific publications, reflecting the high risks and potential of niche pharmaceuticals.
Weekly dynamics of market capitalization of the market segment - Pharma other
Early-stage biotech stocks like Jyong Biotech often move speculatively, reacting to the overall sentiment in the sector. The chart below shows this general pulse of hopes and risks. It allows one to compare whether Jyong's specific niche attracts more or less investor interest than the average biotech startup.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Jyong Biotech is a Taiwanese biotech company. Its shares, like many in the sector, are awaiting clinical trial results. The chart clearly demonstrates how its weekly performance can be detached from overall market movements and driven solely by domestic news.
Market capitalization of the company, segment and market as a whole
MENS - Market capitalization of the company Jyong Biotech Ltd
Jyong Biotech's market capitalization chart shows the market's valuation of its pharmaceutical developments, particularly in cancer treatment. Its volatility directly reflects news about clinical trials and partnerships. The scale of its valuation, even for a biotech company, demonstrates investor interest in its scientific potential.
MENS - Share of the company's market capitalization Jyong Biotech Ltd within the market segment - Pharma other
Jyong Biotech is a niche biopharmaceutical company. Its market capitalization and sector share reflect the stage of its development and investor assessment of the potential of its clinical-stage drugs.
Market capitalization of the market segment - Pharma other
This chart shows the aggregate value of the entire pharmaceutical sector. For Jyong Biotech, a small biotech company working on specialized drugs, this line represents the scale of the ocean in which it operates. The chart's fluctuations reflect global investor sentiment toward the entire industry, against which the company is trying to prove the value of its developments.
Market capitalization of all companies included in a broad market index - GURU.Markets
Jyong Biotech is a biopharmaceutical company focused on developing new drugs. Its market capitalization, like that of many biotech companies, is a measure of its scientific potential and future breakthroughs. Within the overall market, it represents the share of hope for new treatments.
Book value capitalization of the company, segment and market as a whole
MENS - Book value capitalization of the company Jyong Biotech Ltd
Jyong Biotech is a pharmaceutical company whose book value reflects its scientific and manufacturing potential. It includes laboratories, patents for developed drugs, and equipment for their production. How has this material foundation changed during clinical trials? The chart below tells the story.
MENS - Share of the company's book capitalization Jyong Biotech Ltd within the market segment - Pharma other
Jyong Biotech Ltd. is a company whose pharmaceutical research requires a significant material base. Its balance sheet reflects the value of modern laboratories, research equipment, and pilot production lines in Taiwan. The chart shows the company's share of the physical R&D infrastructure in the Asian biotech sector.
Market segment balance sheet capitalization - Pharma other
Jyong Biotech is likely a biotech company. Pharmaceuticals, as the graph shows, are both knowledge- and capital-intensive. Their business requires investment in laboratories and, if successful, in manufacturing facilities to create their drugs.
Book value of all companies included in the broad market index - GURU.Markets
Jyong Biotech develops new drugs, and its assets are intellectual capital backed by a physical base. The company's book value is represented by its laboratories, research equipment, and pilot production facilities. The chart shows the physical foundation upon which biotech research and development is conducted.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Jyong Biotech Ltd
Jyong Biotech is a small biotech company. Its market value is close to its book value, suggesting that investors are currently valuing it primarily on its existing assets and capital. The chart shows that the market is awaiting compelling data to factor in a "hope factor" into the price.
Market to book capitalization ratio in a market segment - Pharma other
Jyong Biotech is a pharmaceutical company focused on developing drugs based on plant extracts. Like most biotech companies, its value lies in the potential of its research and intellectual property. The chart shows investor expectations for future discoveries.
Market to book capitalization ratio for the market as a whole
Jyong Biotech is a Taiwanese biotech company focused on developing drugs based on plant extracts. Its value lies in its unique research and commercialization potential. This chart shows its overall valuation, but how does the market value this small company working at the intersection of traditional medicine and modern science?
Debts of the company, segment and market as a whole
MENS - Company debts Jyong Biotech Ltd
For a small biotech company like Jyong Biotech, which is in the research stage, raising capital is a way to survive and continue operations. In an environment where issuing equity may be unprofitable, debt is becoming an important tool for funding research in anticipation of breakthrough results.
Market segment debts - Pharma other
Jyong Biotech develops drugs based on plant extracts aimed at treating kidney diseases and other conditions. The path from research to commercialization in the pharmaceutical industry is long and expensive. This chart shows how the company funds its clinical trials and how its approach differs from traditional biotech firms.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Jyong Biotech Ltd
Jyong Biotech is a Taiwanese biopharmaceutical company focused on developing drugs for cancer and other diseases. This chart shows its financial structure against the backdrop of expensive R&D. For a research-stage biotech company, debt load is an important indicator of its ability to attract funding to continue clinical trials.
Market segment debt to market segment book capitalization - Pharma other
Biopharmaceutical companies operating in narrow niches, like Jyong Biotech, have a specific financing structure that is highly dependent on the success of their developments. This chart shows the overall debt landscape in the pharmaceutical industry. It allows one to assess how the financial strategy of a small, innovative company differs from that of industry giants and the sector's mid-tier.
Debt to book value of all companies in the market
This chart shows the overall debt level for all companies in the market. Jyong Biotech, a small biopharmaceutical company in the development stage, compares this to the broader market, which is home to many giants, clearly demonstrates how the financial model of a young, investor-dependent research company differs from the overall economy.
P/E of the company, segment and market as a whole
P/E - Jyong Biotech Ltd
This chart for Jyong Biotech, a biopharmaceutical company, shows how investors value its research and development. As with many companies in this industry at the research stage, this ratio can be very high or negative. It reflects not current profits, but rather the company's expectations for the future commercial success of its drugs.
P/E of the market segment - Pharma other
Biotechs, especially those in niche areas like Jyong Biotech, are valued based on potential. This chart shows the average valuation for biopharmaceutical companies. It serves as a benchmark for understanding how investors might value Jyong if its developments in a specific therapeutic area prove successful in the future.
P/E of the market as a whole
Jyong Biotech Ltd. is a biopharmaceutical company specializing in the development of new drugs based on plant extracts for the treatment of various diseases, including cancer and central nervous system disorders. This chart reflects investors' overall risk appetite. It allows one to assess whether MENS's price moves in line with overall sentiment in the biotech sector or is dependent on clinical trial results.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Jyong Biotech Ltd
Jyong Biotech is a Taiwanese biotechnology company specializing in the development of plant-based drugs for the treatment of various diseases. This chart reflects investors' speculative expectations regarding the results of clinical trials and the potential commercialization of its products. Its significance reflects the success of unconventional approaches in pharmaceuticals.
%20P%2FE%20Jyong%20Biotech%20Ltd&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Jyong-Biotech-Ltd&v=1772513898513 "Chart of the company's future (projected) P/E Jyong Biotech Ltd")
Future (projected) P/E of the market segment - Pharma other
Jyong Biotech is a pharmaceutical company focused on developing plant-based drugs for the treatment of various diseases. This chart provides investors with context, showing average profitability expectations in the sector. This allows them to assess how the market perceives its unconventional approach to drug development.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772513898545 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Jyong Biotech is a Taiwanese biotech company developing drugs based on plant extracts. Its success depends on the results of clinical trials and regulatory approval. For such companies, valuations are a bet on a future breakthrough and are largely unrelated to the overall economic expectations visible on the chart.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513898553 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Jyong Biotech Ltd
Jy-ong Biotech (MENS) is a Taiwanese biopharmaceutical company focused on developing new drugs, particularly for the treatment of central nervous system diseases. The company's revenue growth is entirely driven by clinical trials and partnerships. This chart shows the balance between R&D expenses and potential revenue from licensing or sales.
Profit of companies in the market segment - Pharma other
Jyong Biotech is a Taiwanese biopharmaceutical company focused on developing plant-based treatments for a variety of diseases. Its approach combines traditional medicine with modern technology. This chart illustrates the overall dynamics in the niche pharmaceutical sector, where unconventional approaches can open new markets.
Overall market profit
Jyong Biotech is a pharmaceutical company whose future depends on the success of its developments. As with any biotech company, scientific breakthroughs are key. However, the overall economic backdrop, shown in the chart, determines investors' risk appetite and their willingness to fund lengthy and expensive clinical trials.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Jyong Biotech Ltd
Jyong Biotech is a Taiwanese biopharmaceutical company focused on developing plant-based drugs for the treatment of urological and other conditions. Its success depends on the results of clinical trials. This chart reflects analysts' collective expectations regarding the commercial potential of its developments and future profitability.
%20profit%20of%20the%20company%20Jyong%20Biotech%20Ltd&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Jyong-Biotech-Ltd&v=1772513898643 "Graph of future (projected) profit of the company Jyong Biotech Ltd")
Future (predicted) profit of companies in the market segment - Pharma other
Jyong Biotech develops drugs based on plant extracts for the treatment of various diseases. The company operates at the intersection of pharmaceuticals and biotechnology, focusing on natural ingredients. This chart shows profitability forecasts for the pharmaceutical sector, allowing one to assess how the market perceives the potential of companies with unconventional approaches to drug development.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772513898647 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Jyong Biotech is a small pharmaceutical company whose future depends on the outcome of scientific research and clinical trials. Such companies are essentially venture capital investments in science. Their value can rise or fall dramatically based on the results of a single trial, and this is unrelated to the overall economic trends reflected in market profit forecasts.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513898670 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Jyong Biotech Ltd
For the biopharmaceutical company Jyong Biotech, this chart is an indicator of market expectations. It correlates its current market capitalization with sales, which may be modest during the research phase. Thus, it visualizes investors' faith in the scientific potential of its developments and future commercial success.
P/S market segment - Pharma other
Jyong Biotech Ltd. specializes in the development and commercialization of herbal medicines and nutraceuticals, focusing on the treatment of urological diseases. This chart reflects the average revenue estimate for the niche pharmaceutical sector. It provides an insight into the market perception of the company's unique product portfolio and its growth potential in the global market.
P/S of the market as a whole
Jyong Biotech is a Taiwanese biopharmaceutical company focused on developing plant-based drugs for the treatment of various diseases. The company's business is in the research and development phase. This chart provides a general revenue metric that can be used to understand how the market values companies with strong scientific potential but currently lacking stable sales.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Jyong Biotech Ltd
Jyong Biotech is a Taiwanese biopharmaceutical company specializing in the development of herbal extract-based drugs for the treatment of urological diseases. This chart reflects market expectations for future sales of its products. The valuation depends on the success of commercializing its products in global markets and the results of ongoing clinical trials.
%20P%2FS%20Jyong%20Biotech%20Ltd&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Jyong-Biotech-Ltd&v=1772513898763 "The graph of the company's future (projected) P/S Jyong Biotech Ltd")
Future (projected) P/S of the market segment - Pharma other
Jyong Biotech is a biotechnology company developing pharmaceuticals. Like many companies in this sector, its value is largely based on its R&D potential and future sales. This chart reflects market expectations regarding its ability to commercialize its innovations relative to the industry.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772513898779 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Jyong Biotech is a pharmaceutical company focused on developing drugs based on plant extracts. Like many biotech companies, its success depends on research and investment. This chart reflects the overall investment climate. During periods of optimism, investors are more inclined to fund companies with innovative but not yet widely accepted approaches, like Jyong Biotech.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513898785 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Jyong Biotech Ltd
Jyong Biotech develops drugs based on plant extracts, specifically for the treatment of prostate diseases. This chart shows the revenue from sales of its pharmaceutical products. The dynamics here demonstrate the company's commercial success in its niche and the demand for its drugs in Asian and other markets where they operate.
Sales of companies in the market segment - Pharma other
Jyong Biotech Ltd. is a Taiwanese biotechnology company specializing in the development of plant-based drugs for the treatment of various diseases. Its activities can be segmented by specific products or therapeutic areas. This chart reflects the financial flows associated with one of its key research or sales areas.
Overall market sales
Jyong Biotech Ltd. (ticker symbol MENS) develops herbal-based drugs. As a biotech company, its prospects are driven by research results and the potential of new drugs. Its activities reflect growth in the alternative medicine niche and investments in the search for new treatments, which are part of the innovation economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Jyong Biotech Ltd
Jyong Biotech is a company developing herbal medicines. Its future sales forecast, like that of any development-stage biotech company, will reflect analyst expectations regarding the success of clinical trials and potential regulatory approval of its drugs, particularly for the treatment of prostate diseases.
%20sales%20of%20the%20company%20Jyong%20Biotech%20Ltd&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Jyong-Biotech-Ltd&v=1772513898845 "Schedule of future (projected) sales of the company Jyong Biotech Ltd")
Future (projected) sales of companies in the market segment - Pharma other
Jyong Biotech develops herbal-based treatments for a variety of conditions. This chart reflects revenue expectations for the pharmaceutical sector. It provides insight into the commercial potential analysts see in alternative and herbal medicines, providing a general framework for companies operating in this niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772513898862 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Jyong Biotech, a biopharmaceutical company, is focused on developing new drugs. Its market capitalization depends on investors' confidence in the future success of its drugs. This chart of overall market forecasts reflects the overall market risk appetite, which influences the availability of funding for biotech startups.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513898866 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Jyong Biotech Ltd
Jyong Biotech Ltd is a biotechnology company specializing in the development of plant-based drugs for the treatment of various diseases. While in the research and development phase, its financial picture reflects its path to commercialization. This chart shows current research expenditures compared to potential future sales revenue.
Market segment marginality - Pharma other
Jyong Biotech is a pharmaceutical company focused on developing herbal extract-based drugs for the treatment of specific diseases. Profitability in this niche depends on the uniqueness of its formulas, proven clinical efficacy, and patent protection. This chart provides insight into the company's operating model within the context of the pharmaceutical industry.
Market marginality as a whole
Jyong Biotech Ltd. is a pharmaceutical company focused on developing herbal extract-based drugs for the treatment of specific diseases. The company's success depends on clinical evidence of efficacy and regulatory approval. This graph shows average profitability, but for MENS, value is created through scientific research and the potential of its unique developments.
Employees in the company, segment and market as a whole
Number of employees in the company Jyong Biotech Ltd
MENS is an incorrect ticker symbol. A different company may have been intended. However, for any early-stage biotech, the team size chart reflects its journey from scientific idea to clinical trials. Growth in this metric is a marker of successful funding and research progress.
Share of the company's employees Jyong Biotech Ltd within the market segment - Pharma other
Jyiong Biotech is a biotechnology company focused on developing new drugs. Like any research firm, its main resource is its scientists. This chart, reflecting its share of the biopharma talent pool, allows us to assess the scale of its R&D efforts and investment in scientific potential.
Number of employees in the market segment - Pharma other
Jyhong Biotech is a biopharmaceutical company specializing in the development of new drugs. This chart, showing employment in the pharmaceutical industry, illustrates the overall level of investment and activity in the sector. The growing number of researchers indicates a favorable environment for innovation, which is important for companies in clinical development.
Number of employees in the market as a whole
Jyong Biotech is a pharmaceutical company whose operations are less dependent on economic cycles. Nevertheless, a strong labor market, as shown in this chart, is important. It ensures stability in the healthcare and insurance systems, guaranteeing patients access to new treatments once they are approved and commercialized.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Jyong Biotech Ltd (MENS)
Information about Jyong Biotech Ltd (MENS) is limited, but as a biotech company, it likely develops new drugs. In this sector, high market capitalization per employee is the norm. This chart shows that the market values the potential of intellectual property created by a small team of scientists rather than current assets.
%20of%20the%20company%20Jyong%20Biotech%20Ltd%20(MENS)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Jyong-Biotech-Ltd-MENS&v=1772513899029 "Chart of market capitalization per employee (in thousands of dollars) of the company Jyong Biotech Ltd (MENS)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Jyong Biotech (MENS) is a biotech company focused on developing plant-based drugs. Its value lies in its R&D pipeline and its hopes for future blockbusters. This chart shows the (often volatile) market value the market assigns to each of its research scientists.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772513899128 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Jyong Biotech Ltd. (MENS) is a Taiwanese biotechnology company focused on developing drugs based on plant extracts. Their value depends on the success of clinical trials and the patenting of new drugs. The chart reflects the market's speculative valuation of the scientific potential concentrated in a small research team.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513899153 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Jyong Biotech Ltd (MENS)
Jyong Biotech Ltd (MENS) is a biotech company, likely focused on drug development (as its name suggests). *Note: MENS is a non-standard ticker symbol, possibly an ADR or Taiwanese one.* Earnings per employee in biotech, especially in the early stages, are often negative. This chart shows research intensity; it measures how much capital is invested in each scientist in hopes of a future breakthrough.
%20Chart%20Jyong%20Biotech%20Ltd%20(MENS)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Jyong-Biotech-Ltd-MENS&v=1772513899159 "Company Profit Per Employee (in thousands of dollars) Chart Jyong Biotech Ltd (MENS)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Jyong Biotech is a Taiwanese biotech company developing drugs based on plant extracts (phytopharmaceuticals). This chart shows the benchmark for "Other Pharma." In this R&D sector, the benchmark is likely *negative*. Companies are burning money on R&D. Profit per scientist is the goal of the future.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772513899179 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Jyong Biotech (MENS) is a Taiwanese biotech company specializing in the development of new plant-based drugs (phytopharmaceuticals) for the treatment of urological diseases and cancer. This graph, showing average profit per employee, is important for biotech. It allows one to assess how much a sector where a handful of scientists can create a breakthrough drug outperforms the "average" labor efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513899181 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Jyong Biotech Ltd (MENS)
Jyong Biotech is a pharmaceutical company focused on drug development. At this stage, its operations may not generate stable revenue. This graph will eventually show how commercially successful its developments will be and how scientific advances will be converted into revenue per employee.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Jyong-Biotech-Ltd-MENS&v=1772513899196 "Sales chart per company employee Jyong Biotech Ltd (MENS)")
Sales per employee in the market segment - Pharma other
Jyong Biotech develops new drugs, including those for cancer and central nervous system diseases. It is a research-stage biotech company. This chart shows revenue per employee. Comparing with the segment helps investors understand how the company manages its R&D and personnel expenses during the long journey to commercialization.
Sales per employee for the market as a whole
Jyong Biotech (MENS) is a biotech company specializing in the development of plant-based drugs for the treatment of various diseases. Being in the research and development (R&D) stage, the company may not have stable commercial revenue. This chart will show either $0 or revenue from occasional licensing agreements, reflecting the early stage of business development.
Short shares by company, segment and market as a whole
Shares shorted by company Jyong Biotech Ltd (MENS)
Jyong Biotech is a biotech company focused on developing drugs, often based on plant-based compounds, for the treatment of various diseases. Companies of this type face high levels of investor skepticism due to the difficulty of proving efficacy. This chart shows the number of those who doubt the company's scientific foundation and its chances of regulatory approval.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Jyong-Biotech-Ltd-MENS&v=1772513899263 "Short Shares Chart for the Company Jyong Biotech Ltd (MENS)")
Shares shorted by market segment - Pharma other
Jyong Biotech (MENS) is a Taiwanese biopharmaceutical company developing drugs based on plant extracts, particularly for the treatment of prostate conditions. This chart shows the betting against the niche pharmaceutical sector, reflecting the high level of investor skepticism regarding the ability of such companies to successfully complete clinical trials and reach the market.
Shares shorted by the overall market
Jyong Biotech (MENS) is a speculative biotech company. This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and dump risk, especially unprofitable biotechs. This pessimism, visible on the chart, deprives MENS of access to the capital needed for research.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Jyong Biotech Ltd (MENS)
Jyong Biotech (MENS) is a speculative biotech company. When this general fear indicator rises, investors sell small, illiquid, and unprofitable companies like MENS, preferring blue chips. This chart for MENS reflects the general panic/euphoria in biotech rather than the specifics of the business.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Jyong-Biotech-Ltd-MENS&v=1772513899291 "RSI 14 indicator chart for the company's stock Jyong Biotech Ltd (MENS)")
RSI 14 Market Segment - Pharma other
Jyong Biotech (MENS) is a Taiwanese biotech company focused on developing botanical-based drugs for the treatment of conditions such as cancer and genitourinary diseases. This indicator reflects the overall sentiment across the entire "other pharma" sector. It helps us understand whether MENS shares are overheated by unique R&D news or whether the entire speculative biotech sector is in a rally.
RSI 14 for the overall market
Jyong Biotech (MENS) is a biotech company, and its relationship to this chart is typical for the sector. Market euphoria is a "green light" for raising capital for research. Market panic is a "red light," when investors flee speculative ventures, and the company is forced to survive on its existing funds, cutting back on R&D.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MENS (Jyong Biotech Ltd)
Jyong Biotech is a Taiwanese biotech company specializing in the development of new plant-based drugs, particularly for the treatment of cancer and prostate diseases. This chart shows the average analyst forecast. For such a highly specialized company, forecasts (if any) are based on clinical trial data and the potential of their niche drugs.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-MENS-Jyong-Biotech-Ltd&v=1772513899319 "A chart showing analyst consensus forecasts for the expected stock price. MENS (Jyong Biotech Ltd)")
The difference between the consensus estimate and the actual stock price MENS (Jyong Biotech Ltd)
Tailored Brands (MENS) is one of the largest men's formalwear retailers in the US, owning the Men's Wearhouse and Jos. A. Bank chains. This chart provides a look at their complex market. It measures the gap between the price and the consensus target, reflecting whether analysts believe demand for office and wedding wear will recover after the pandemic.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-MENS-Jyong-Biotech-Ltd&v=1772513899342 "A chart showing the difference between the consensus forecast and the actual stock price. MENS (Jyong Biotech Ltd)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Jyong Biotech is a Taiwanese biopharmaceutical company specializing in the development of herbal medicines for the treatment of urological diseases and Alzheimer's disease. This chart shows analysts' overall expectations for the pharmaceutical sector, reflecting whether experts believe in the potential of R&D pipelines in this niche.
Analysts' consensus forecast for the overall market share price
Jyong Biotech Ltd. (MENS) is a Taiwanese biotech company specializing in the development of plant-based drugs for the treatment of men's health conditions. This chart shows the overall risk appetite. For a small biotech company like Jyong, overall market optimism is important for attracting investor attention and funding research in a highly competitive field.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Jyong Biotech Ltd
Jyong Biotech is a biotech company specializing in the development of new plant-based drugs for the treatment of specific diseases, such as cancer and urological conditions. This chart evaluates their R&D platform. It reflects investors' confidence in their scientific approach and the potential of their candidates undergoing clinical trials.
AKIMA Market Segment Index - Pharma other
Jyong Biotech is a Taiwanese biotech company focused on developing botanical medicines (R&D) for the treatment of urological diseases and improving quality of life. This summary metric evaluates R&D. The graph shows the average value for the segment. This benchmark: how does Jyong's unique botanical R&D platform differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Jyong Biotech is a biotech company focused on developing botanical medicines for the treatment of various diseases. It's a high-risk scientific bet. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this speculative story, driven by trial news, compares to overall economic trends.
